Hosts of “The View” made it clear that they weren’t happy that President-elect Donald Trump’s pick for Secretary of Health and Human Services Robert F. Kennedy Jr. might crack down on weight loss drugs like Ozempic.
During Thursday’s episode of the ABC talk show, cohost Whoopi Goldberg unleashed a rant against RFK. Jr. whom she said plans to crack down on the off-label use of Ozempic by people who want to manage their weight because Americans are “addicted to drugs and weight loss should come from diet and exercise.”
“Why should a numbers cruncher with no medical background have any say? I don’t understand why you want to be in my business!” Goldberg said, as her cohosts Alyssa Farah Griffin, Sunny Hostin, and Sara Haines agreed.
The View is upset that RFK Jr. is looking to crack down on the off-label use of Ozempic to manage their weight. Whoopi scoffs at the idea that weight loss should come from diet and exercise.
“I don’t understand why you want to be in my business!” she whines. pic.twitter.com/QSETmQRb58— Nicholas Fondacaro (@NickFondacaro) December 12, 2024
Goldberg argued that managing weight wasn’t just about food and said sometimes people are “born genetically larger.”
“I want to say this to [RFK Jr.] because you’re setting folks up for shame,” Whoopi said. “That’s what you’re trying … maybe you don’t know you’re doing … I’m going to give you the benefit of the doubt.”
CHECK OUT THE DAILY WIRE HOLIDAY GIFT GUIDE
“I’m gonna say you don’t realize what you do to people when you say [what you said] because it doesn’t work for everybody. I’m going to show you sir, because I weighed close to 300 pounds less than two years ago and without the Mounjaro, this would not have happened,” she added, before she stood up and showed off her slimmer physique.
“You cannot take it out of people’s hands if it could help,” Goldberg continued. “If we can keep people healthy. If we can get rid of diabetes. If we can get rid of all the things, cardiovascular, what’s wrong with trying to do that?”
Joy Behar interjected, “Nothing,” before Whoopi continued calling out RFK Jr. and said he was wrong about weight loss drugs.
Drugs to manage weight have become a hot topic as a growing number of people seek their weight loss benefits.
However, some unpleasant side effects of taking these types of drugs include gastrointestinal problems, including abdominal pain, nausea, and vomiting. There is also a potential risk of thyroid tumors and cancer associated with [Novo Nordisk’s] Ozempic, another popular option, according to studies done with rodents, as The Daily Wire previously reported.
A recent head-to-head study between two popular weight loss drugs, Eli Lilly’s Zepbound and Novo Nordisk’s Wegovy, showed that users lost more weight using Zepbound.
According to the study, which was sponsored by Lilly, people using Zepbound lost 20.2% of their body weight over 72 weeks, while Wegovy users lost 13.7%. In pounds, that means Zepbound users lost an average of 50 lbs, while Wegovy users lost 33.
Amanda Harding contributed to this piece.
Related: Weight Loss Wars: New Study Weighs In On Effectiveness Of Popular Obesity Drugs
[#item_full_content]
[[{“value”:”
Hosts of “The View” made it clear that they weren’t happy that President-elect Donald Trump’s pick for Secretary of Health and Human Services Robert F. Kennedy Jr. might crack down on weight loss drugs like Ozempic.
During Thursday’s episode of the ABC talk show, cohost Whoopi Goldberg unleashed a rant against RFK. Jr. whom she said plans to crack down on the off-label use of Ozempic by people who want to manage their weight because Americans are “addicted to drugs and weight loss should come from diet and exercise.”
“Why should a numbers cruncher with no medical background have any say? I don’t understand why you want to be in my business!” Goldberg said, as her cohosts Alyssa Farah Griffin, Sunny Hostin, and Sara Haines agreed.
The View is upset that RFK Jr. is looking to crack down on the off-label use of Ozempic to manage their weight. Whoopi scoffs at the idea that weight loss should come from diet and exercise.
“I don’t understand why you want to be in my business!” she whines. pic.twitter.com/QSETmQRb58— Nicholas Fondacaro (@NickFondacaro) December 12, 2024
Goldberg argued that managing weight wasn’t just about food and said sometimes people are “born genetically larger.”
“I want to say this to [RFK Jr.] because you’re setting folks up for shame,” Whoopi said. “That’s what you’re trying … maybe you don’t know you’re doing … I’m going to give you the benefit of the doubt.”
CHECK OUT THE DAILY WIRE HOLIDAY GIFT GUIDE
“I’m gonna say you don’t realize what you do to people when you say [what you said] because it doesn’t work for everybody. I’m going to show you sir, because I weighed close to 300 pounds less than two years ago and without the Mounjaro, this would not have happened,” she added, before she stood up and showed off her slimmer physique.
“You cannot take it out of people’s hands if it could help,” Goldberg continued. “If we can keep people healthy. If we can get rid of diabetes. If we can get rid of all the things, cardiovascular, what’s wrong with trying to do that?”
Joy Behar interjected, “Nothing,” before Whoopi continued calling out RFK Jr. and said he was wrong about weight loss drugs.
Drugs to manage weight have become a hot topic as a growing number of people seek their weight loss benefits.
However, some unpleasant side effects of taking these types of drugs include gastrointestinal problems, including abdominal pain, nausea, and vomiting. There is also a potential risk of thyroid tumors and cancer associated with [Novo Nordisk’s] Ozempic, another popular option, according to studies done with rodents, as The Daily Wire previously reported.
A recent head-to-head study between two popular weight loss drugs, Eli Lilly’s Zepbound and Novo Nordisk’s Wegovy, showed that users lost more weight using Zepbound.
According to the study, which was sponsored by Lilly, people using Zepbound lost 20.2% of their body weight over 72 weeks, while Wegovy users lost 13.7%. In pounds, that means Zepbound users lost an average of 50 lbs, while Wegovy users lost 33.
Amanda Harding contributed to this piece.
Related: Weight Loss Wars: New Study Weighs In On Effectiveness Of Popular Obesity Drugs
“}]]
